Enochian Biosciences, Inc.
USD0.71
+0.01 (+1.79%)
CEO
Mark R. Dybul
IPO Date
2018-02-07
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$0.73
Prev. Close
$0.70
Day Low
$0.70
Day High
$0.74
52W Low
$0.39
52W High
$2.99
Market Cap
$0.05B
Volume
0.09M
| -1.9 |
| 30 Jun 2023 | FY | 0.0% | 0.0% | -85.3% | -68.1% | 0.12 | 0.23 | -0.8 |
| 30 Jun 2022 | FY | 0.0% | 0.0% | -156.2% | -134.0% | 0.10 | 1.48 | -0.9 |
| 30 Jun 2021 | FY | 0.0% | 0.0% | -15.3% | -14.1% | 0.04 | 11.08 | -8.8 |
| 30 Jun 2020 | FY | 0.0% | 0.0% | -6.9% | -6.4% | 0.05 | 6.70 | -17.1 |
| 30 Jun 2019 | FY | 0.0% | 0.0% | -10.4% | -10.0% | 0.00 | 11.25 | -9.3 |
| 30 Jun 2018 | FY | 0.0% | 0.0% | -4.0% | -3.5% | 0.00 | 18.04 | -11.5 |
| 30 Jun 2017 | FY | 0.0% | 0.0% | -139.8% | -47.4% | 1.36 | 1.40 | -33.8 |
| 30 Jun 2016 | FY | 23.6% | -4057.2% | 272.2% | -199.3% | -0.16 | 0.49 | -32.4 |
| -3.4 |
| 30 Sept 2025 | Q1 | 0.0% | 0.0% | -21.6% | 40.5% | -0.21 | 0.04 | 2.5 |
| 30 Jun 2025 | Q4 | 50.0% | -65686.2% | 593.6% | -1539.7% | -0.48 | 0.04 | -0.9 |
| 31 Mar 2025 | Q3 | 0.0% | 0.0% | 0.2% | 0.2% | 0.09 | 0.13 | 116.5 |
| 31 Dec 2024 | Q2 | 0.0% | 0.0% | -8.8% | -6.5% | 0.08 | 0.06 | -4.7 |
| 30 Sept 2024 | Q1 | 0.0% | 0.0% | -45.1% | -36.3% | 0.04 | 0.08 | -0.4 |
| 30 Jun 2024 | Q4 | 50.0% | -8669.8% | -11.9% | -9.6% | 0.03 | 0.07 | -2.4 |
| 31 Mar 2024 | Q3 | 0.0% | 0.0% | -10.1% | -8.0% | 0.05 | 0.06 | -4.7 |
| 31 Dec 2023 | Q2 | 0.0% | 0.0% | -10.4% | -7.8% | 0.17 | 0.17 | -11.5 |